The evidence currently available indicates that GLP-1 RA could add to the arsenal available to address persistent gaps in the care of people living with T2DM with, or at the risk of, developing CKD and to reduce the residual renal risk present in those who have already developed CKD
(Initial analysis indicates that body weight reduction with survodutide was driven predominantly by "loss of fat" tissue, with "lean mass" contributing only a small proportion of total weight!) The trial met both weight loss primary endpoints + its key secondary endpoint evaluating waist circumference(a predictor of cardiometabolic risk) together demonstrating survodutide's potential to broadly improve metabolic health
Dont inject into muscles, veins, or scars, and dont use areas of skin that are red, bruised, or cut
Raju Kandel, Arizona State University, United States Updates Copyright 2018 Kumar and Trivedi
Protect your skin from the sun by using a sunscreen with high protection (SPF 50+) to avoid exposing your skin to ultraviolet rays that may cause irritation or pigmentation
